IRWD
Price
$3.96
Change
-$0.62 (-13.54%)
Updated
Jan 10 closing price
Capitalization
1.36B
33 days until earnings call
PBH
Price
$74.00
Change
-$0.38 (-0.51%)
Updated
Jan 10 closing price
Capitalization
3.6B
26 days until earnings call
Ad is loading...

IRWD vs PBH

Header iconIRWD vs PBH Comparison
Open Charts IRWD vs PBHBanner chart's image
Ironwood Pharmaceuticals
Price$3.96
Change-$0.62 (-13.54%)
Volume$1.69M
Capitalization1.36B
Prestige Consumer Healthcare
Price$74.00
Change-$0.38 (-0.51%)
Volume$330.21K
Capitalization3.6B
IRWD vs PBH Comparison Chart
Loading...
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRWD vs. PBH commentary
Jan 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRWD is a Hold and PBH is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 12, 2025
Stock price -- (IRWD: $3.96 vs. PBH: $74.00)
Brand notoriety: IRWD and PBH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: IRWD: 78% vs. PBH: 114%
Market capitalization -- IRWD: $1.36B vs. PBH: $3.6B
IRWD [@Pharmaceuticals: Other] is valued at $1.36B. PBH’s [@Pharmaceuticals: Other] market capitalization is $3.6B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRWD’s FA Score shows that 1 FA rating(s) are green whilePBH’s FA Score has 1 green FA rating(s).

  • IRWD’s FA Score: 1 green, 4 red.
  • PBH’s FA Score: 1 green, 4 red.
According to our system of comparison, PBH is a better buy in the long-term than IRWD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRWD’s TA Score shows that 3 TA indicator(s) are bullish while PBH’s TA Score has 4 bullish TA indicator(s).

  • IRWD’s TA Score: 3 bullish, 6 bearish.
  • PBH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PBH is a better buy in the short-term than IRWD.

Price Growth

IRWD (@Pharmaceuticals: Other) experienced а -12.20% price change this week, while PBH (@Pharmaceuticals: Other) price change was -3.75% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.46%. For the same industry, the average monthly price growth was -1.10%, and the average quarterly price growth was -10.50%.

Reported Earning Dates

IRWD is expected to report earnings on May 01, 2025.

PBH is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.46% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($3.6B) has a higher market cap than IRWD($1.36B). PBH has higher P/E ratio than IRWD: PBH (14.90) vs IRWD (10.31). PBH YTD gains are higher at: -5.238 vs. IRWD (-10.609). PBH has higher annual earnings (EBITDA): 10.8M vs. IRWD (-924.84M). IRWD has more cash in the bank: 92.2M vs. PBH (63.6M). IRWD has less debt than PBH: IRWD (716M) vs PBH (1.21B). PBH has higher revenues than IRWD: PBH (1.13B) vs IRWD (443M).
IRWDPBHIRWD / PBH
Capitalization1.36B3.6B38%
EBITDA-924.84M10.8M-8,563%
Gain YTD-10.609-5.238203%
P/E Ratio10.3114.9069%
Revenue443M1.13B39%
Total Cash92.2M63.6M145%
Total Debt716M1.21B59%
FUNDAMENTALS RATINGS
IRWD vs PBH: Fundamental Ratings
IRWD
PBH
OUTLOOK RATING
1..100
1958
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
10011
SMR RATING
1..100
10061
PRICE GROWTH RATING
1..100
5851
P/E GROWTH RATING
1..100
2838
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PBH's Valuation (75) in the Pharmaceuticals Other industry is in the same range as IRWD (84). This means that PBH’s stock grew similarly to IRWD’s over the last 12 months.

PBH's Profit vs Risk Rating (11) in the Pharmaceuticals Other industry is significantly better than the same rating for IRWD (100). This means that PBH’s stock grew significantly faster than IRWD’s over the last 12 months.

PBH's SMR Rating (61) in the Pharmaceuticals Other industry is somewhat better than the same rating for IRWD (100). This means that PBH’s stock grew somewhat faster than IRWD’s over the last 12 months.

PBH's Price Growth Rating (51) in the Pharmaceuticals Other industry is in the same range as IRWD (58). This means that PBH’s stock grew similarly to IRWD’s over the last 12 months.

IRWD's P/E Growth Rating (28) in the Pharmaceuticals Other industry is in the same range as PBH (38). This means that IRWD’s stock grew similarly to PBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRWDPBH
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
70%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
53%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
66%
Bearish Trend 4 days ago
47%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 17 days ago
60%
Declines
ODDS (%)
Bearish Trend 13 days ago
81%
Bearish Trend 5 days ago
53%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
78%
Aroon
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
40%
View a ticker or compare two or three
Ad is loading...
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVCFX14.46N/A
N/A
Pioneer Disciplined Value C
FTRNX185.22N/A
N/A
Fidelity Trend
BRTNX74.07N/A
N/A
Bretton Fund
FGRSX35.28N/A
N/A
Federated Hermes Intl Leaders R6
CWMEX60.28-0.77
-1.26%
American Funds Washington Mutual 529E

IRWD and

Correlation & Price change

A.I.dvisor tells us that IRWD and ACET have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
-13.54%
ACET - IRWD
30%
Poorly correlated
-4.47%
PRGO - IRWD
29%
Poorly correlated
-2.67%
ASRT - IRWD
26%
Poorly correlated
+0.69%
AMPH - IRWD
25%
Poorly correlated
-0.74%
ELAN - IRWD
24%
Poorly correlated
-1.04%
More

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
-0.51%
PAHC - PBH
34%
Loosely correlated
-6.66%
IRWD - PBH
32%
Poorly correlated
-13.54%
SUPN - PBH
28%
Poorly correlated
-1.50%
EBS - PBH
26%
Poorly correlated
-2.08%
PRGO - PBH
25%
Poorly correlated
-2.67%
More